C4 Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.

CEO

Andrew J. Hirsch

CEOAndrew J. Hirsch

Employees

121

Employees121

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2015

Founded2015

Employees

121

Employees121

CCCC Key Statistics

Market cap

392.64M

Market cap392.64M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

529.83K

Average volume529.83K

High today

$8.70

High today$8.70

Low today

$7.68

Low today$7.68

Open price

$7.87

Open price$7.87

Volume

928.30K

Volume928.30K

52 Week high

$38.05

52 Week high$38.05

52 Week low

$4.84

52 Week low$4.84

Analyst ratings

62%

of 13 ratings

Buy

61.5%

Hold

23.1%

Sell

15.4%

CCCC Earnings

-$0.69

-$0.46

-$0.23

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 23, Pre-Market

ActualExpected Feb 23, Pre-Market